The role of IKK in constitutive activation of NF-κB transcription factor in prostate carcinoma cells

Journal of Cell Science

Volumn 115, Issue 1, 2002, Pages 141-151

  Gasparian, Alexander V ^a   Yao, Ya Juan ^a   Kowalczyk, Dariusz ^a   Lyakh, Ludmila A ^a   Karseladze, Apollon ^a   Slaga, Thomas J ^a   Budunova, Irina V ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

I B phosphorylation; IKK; NF B; Prostate cancer

Indexed keywords

ANDROGEN; I KAPPA B ALPHA; I KAPPA B BETA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOTRANSFERASE; PROTEIN INHIBITOR; PROTEIN P50; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA; ENZYME ACTIVATION; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; KINETICS; MALE; MUTATION; NF-KAPPA B; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0036150911     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. The NF-kappa B and I kappa B proteins: New discoveries and insights
2. Control of apoptosis by Rel/NF-kappaB transcription factors
3. Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells
4. Human RelB [I-Rel] functions as a kappa B site-dependent transactivating member of the family of Rel-related proteins
5. Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis
6. Fibroblast growth factor-1 [FGF-1] enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor-bearing Jurkat T cells
7. Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha
8. Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells
9. Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cells
10. Elevated constitutive IkappaB kinase activity and IkappaB-alpha phosphorylation in Hs294T melanoma cells lead to increased basal MGSA/GRO-alpha transcription
11. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo
12. Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells
13. Analysis of constitutive and induced NF-kappaB complexes in prostate carcinoma cell lines
14. Nerve growth factor activation of nuclear factor kappaB through its p75 receptor is an anti-apoptotic signal in RN22 schwannoma cells
15. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1
16. A simplified system for generating recombinant adenoviruses
17. NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes
18. NF-kappaB function in growth control: Regulation of cyclin D1 expression and G0/G1-to-S-phase transition
19. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo
20. Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells
21. Promoter analysis of the gene encoding the I kappa B-alpha/MAD3 inhibitor of NF-kappa B: Positive regulation by members of the rel/NF-kappa B family
22. Bacterial lipopolysaccharide, TNF-alpha, and calcium ionophore under serum-free conditions promote rapid dendritic cell-like differentiation in CD14+ monocytes through distinct pathways that activate NF-kappaB
23. Catalysis by a multiprotein IkappaB kinase complex
24. IKK-1 and IKK-2: Cytokine-activated IkappaB kinases essential for NF-kappaB activation
25. Phenotypic and genotypic characterization of commonly used human prostatic cell lines
26. Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells
27. Establishment of new human prostatic cancer cell line [JCA-1]
28. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth
29. Activation of the heterodimeric IkappaB kinase alpha (IKKalpha-IKKbeta) complex is directional: IKKalpha regulates IKKbeta under both basal and stimulated conditions
30. Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen
31. Mutual transcriptional interference between RelA and androgen receptor
32. Aberrant rel/nfkb genes and activity in human cancer
33. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling
34. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase
35. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer
36. An essential role for nuclear factor kappa B in preventing TNF-alpha-induced cell death in prostate cancer cells
37. Epidermal growth factor activation of NF-kappaB is mediated through IkappaBalpha degradation and intracellular free calcium
38. Nuclear factor kappa B functions as a negative regulator for the rat androgen receptor gene and NF-kappa B activity increases during the age-dependent desensitization of the liver
39. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli
40. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells
41. Mutations in the estrogen receptor ligand binding domain discriminate between hormone-dependent transactivation and transrepression
42. Suppression of TNF-alpha-induced apoptosis by NF-kappaB
43. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression
44. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB
45. I kappa B proteins: Structure, function and regulation
46. N- and C-terminal sequences control degradation of MAD3/I kappa B alpha in response to inducers of NF-kappa B activity
47. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation
48. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation
49. Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-kappa B